Interline Therapeutics, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Interline Therapeutics, Inc. - overview
Established
2020
Location
South San Francisco, CA, US
Primary Industry
Pharmaceuticals
About
Based in California, US, and founded in 2020 by Zach Sweeney, a scientist with a track record of growing and leading successful drug discovery groups. Interline Therapeutics, Inc. operates as a pharmaceutical company focused on the research and development of therapeutic drugs for the prevention or treatment of human diseases. In May 2021, the company received Series A funding led by Foresite Capital and ARCH Venture Partners.
Interline Therapeutics uses genomics, proteomics, structural biology, and computational chemistry to systematically map and modulate protein communities. This will allow the company to identify new medicines targeting genetically validated signaling pathways and ensure that drug candidates comprehensively correct dysfunctional disease networks. Interline Therapeutics intends to use the funds to double its team, expand its platform and drive six programs through preclinical development.
Current Investors
ARCH Venture Partners, Foresite Capital
Primary Industry
Pharmaceuticals
Sub Industries
Biopharmaceuticals, Molecular Science, Genetics & Gene Therapy, Pharmaceutical Research & Development
Website
www.interlinetx.com
Company Stage
Series A
Total Amount Raised
Subscriber access only
Interline Therapeutics, Inc. - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.